{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:04:14Z","timestamp":1788375854676,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12969-016-0106-4","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T04:53:53Z","timestamp":1469854433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study"],"prefix":"10.1186","volume":"14","author":[{"name":"on behalf of the Pregabalin Adolescent Fibromyalgia Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0393-9948","authenticated-orcid":false,"given":"Lesley M.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth N.","family":"Schikler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahira","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Pauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritha","family":"Bhadra-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marci L.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Scavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,30]]},"reference":[{"key":"106_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","volume":"38","author":"F Wolfe","year":"1995","unstructured":"Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19\u201328.","journal-title":"Arthritis Rheum"},{"key":"106_CR2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160\u201372.","journal-title":"Arthritis Rheum"},{"key":"106_CR3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/art.24099","volume":"59","author":"S Kashikar-Zuck","year":"2008","unstructured":"Kashikar-Zuck S, Lynch AM, Slater S, Graham TB, Swain NF, Noll RB. Family factors, emotional functioning, and functional impairment in juvenile fibromyalgia syndrome. Arthritis Rheum. 2008;59:1392\u20138.","journal-title":"Arthritis Rheum"},{"key":"106_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.22615","volume":"57","author":"S Kashikar-Zuck","year":"2007","unstructured":"Kashikar-Zuck S, Lynch AM, Graham TB, Swain NF, Mullen SM, Noll RB. Social functioning and peer relationships of adolescents with juvenile fibromyalgia syndrome. Arthritis Rheum. 2007;57:474\u201380.","journal-title":"Arthritis Rheum"},{"key":"106_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.berh.2011.02.005","volume":"25","author":"K Phillips","year":"2011","unstructured":"Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states--maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011;25:141\u201354.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"106_CR6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/art.20042","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, Starck LO, Keck Jr PE. Family study of fibromyalgia. Arthritis Rheum. 2004;50:944\u201352.","journal-title":"Arthritis Rheum"},{"key":"106_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrrheum.2013.177","volume":"10","author":"S Kashikar-Zuck","year":"2014","unstructured":"Kashikar-Zuck S, Ting TV. Juvenile fibromyalgia: current status of research and future developments. Nat Rev Rheumatol. 2014;10:89\u201396.","journal-title":"Nat Rev Rheumatol"},{"key":"106_CR8","doi-asserted-by":"crossref","first-page":"e592","DOI":"10.1542\/peds.2013-2220","volume":"133","author":"S Kashikar-Zuck","year":"2014","unstructured":"Kashikar-Zuck S, Cunningham N, Sil S, Bromberg MH, Lynch-Jordan AM, Strotman D, Peugh J, Noll J, Ting TV, Powers SW, et al. Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood. Pediatrics. 2014;133:e592\u2013600.","journal-title":"Pediatrics"},{"key":"106_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.rdc.2009.06.001","volume":"35","author":"D Buskila","year":"2009","unstructured":"Buskila D. Pediatric fibromyalgia. Rheum Dis Clin North Am. 2009;35:253\u201361.","journal-title":"Rheum Dis Clin North Am"},{"key":"106_CR10","first-page":"368","volume":"20","author":"D Buskila","year":"1993","unstructured":"Buskila D, Press J, Gedalia A, Klein M, Neumann L, Boehm R, Sukenik S. Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol. 1993;20:368\u201370.","journal-title":"J Rheumatol"},{"key":"106_CR11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1542\/peds.100.2.220","volume":"100","author":"M Mikkelsson","year":"1997","unstructured":"Mikkelsson M, Sourander A, Piha J, Salminen JJ. Psychiatric symptoms in preadolescents with musculoskeletal pain and fibromyalgia. Pediatrics. 1997;100:220\u20137.","journal-title":"Pediatrics"},{"key":"106_CR12","first-page":"2009","volume":"25","author":"P Clark","year":"1998","unstructured":"Clark P, Burgos-Vargas R, Medina-Palma C, Lavielle P, Marina FF. Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol. 1998;25:2009\u201314.","journal-title":"J Rheumatol"},{"key":"106_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jadohealth.2005.05.018","volume":"38","author":"AL Zapata","year":"2006","unstructured":"Zapata AL, Moraes AJ, Leone C, Doria-Filho U, Silva CA. Pain and musculoskeletal pain syndromes in adolescents. J Adolesc Health. 2006;38:769\u201371.","journal-title":"J Adolesc Health"},{"key":"106_CR14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/art.30644","volume":"64","author":"S Kashikar-Zuck","year":"2012","unstructured":"Kashikar-Zuck S, Ting TV, Arnold LM, Bean J, Powers SW, Graham TB, Passo MH, Schikler KN, Hashkes PJ, Spalding S, et al. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum. 2012;64:297\u2013305.","journal-title":"Arthritis Rheum"},{"key":"106_CR15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/art.24115","volume":"59","author":"S Stephens","year":"2008","unstructured":"Stephens S, Feldman BM, Bradley N, Schneiderman J, Wright V, Singh-Grewal D, Lefebvre A, Benseler SM, Cameron B, Laxer R, et al. Feasibility and effectiveness of an aerobic exercise program in children with fibromyalgia: results of a randomized controlled pilot trial. Arthritis Rheum. 2008;59:1399\u2013406.","journal-title":"Arthritis Rheum"},{"key":"106_CR16","unstructured":"Cymbalta\u00ae (duloxetine) (prescribing information) [URL: http:\/\/pi.lilly.com\/us\/cymbalta-pi.pdf ]. Accessed 5 May 2016."},{"key":"106_CR17","unstructured":"Lyrica\u00ae (pregabalin) (prescribing information) [URL: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=561 ]. Accessed 5 May 2016."},{"key":"106_CR18","unstructured":"Savella\u00ae (milnacipran) (prescribing information) [URL: http:\/\/www.frx.com\/pi\/savella_pi.pdf ]. Accessed 5 May 2016."},{"key":"106_CR19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/JCP.0b013e31824858dc","volume":"32","author":"EN Mariutto","year":"2012","unstructured":"Mariutto EN, Stanford SB, Kashikar-Zuck S, Welge JA, Arnold LM. An exploratory, open trial of fluoxetine treatment of juvenile fibromyalgia. J Clin Psychopharmacol. 2012;32:293\u20135.","journal-title":"J Clin Psychopharmacol"},{"key":"106_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-015-0025-9","volume":"13","author":"LM Arnold","year":"2015","unstructured":"Arnold LM, Bateman L, Palmer RH, Lin Y. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. Pediatr Rheumatol Online J. 2015;13:27.","journal-title":"Pediatr Rheumatol Online J"},{"key":"106_CR21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","volume":"9","author":"LM Arnold","year":"2008","unstructured":"Arnold LM, Russell IJ, Diri EW, Duan WR, Young Jr JP, Sharma U, Martin SA, Barrett JA, Haig G. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008;9:792\u2013805.","journal-title":"J Pain"},{"key":"106_CR22","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","volume":"52","author":"LJ Crofford","year":"2005","unstructured":"Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, Young Jr JP, LaMoreaux LK, Martin SA, Sharma U. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264\u201373.","journal-title":"Arthritis Rheum"},{"key":"106_CR23","first-page":"502","volume":"35","author":"PJ Mease","year":"2008","unstructured":"Mease PJ, Russell IJ, Arnold LM, Florian H, Young Jr JP, Martin SA, Sharma U. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008;35:502\u201314.","journal-title":"J Rheumatol"},{"key":"106_CR24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/art.1780280205","volume":"28","author":"MB Yunus","year":"1985","unstructured":"Yunus MB, Masi AT. Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls. Arthritis Rheum. 1985;28:138\u201345.","journal-title":"Arthritis Rheum"},{"key":"106_CR25","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2783","volume":"11","author":"RM Bennett","year":"2009","unstructured":"Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11:R120.","journal-title":"Arthritis Res Ther"},{"key":"106_CR26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1529-0131(199604)9:2<89::AID-ANR1790090204>3.0.CO;2-J","volume":"9","author":"LE Schanberg","year":"1996","unstructured":"Schanberg LE, Keefe FJ, Lefebvre JC, Kredich DW, Gil KM. Pain coping strategies in children with juvenile primary fibromyalgia syndrome: correlation with pain, physical function, and psychological distress. Arthritis Care Res. 1996;9:89\u201396.","journal-title":"Arthritis Care Res"},{"key":"106_CR27","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3899\/jrheum.110569","volume":"38","author":"L Pauer","year":"2011","unstructured":"Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. J Rheumatol. 2011;38:2643\u201352.","journal-title":"J Rheumatol"},{"key":"106_CR28","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1186\/ar4056","volume":"14","author":"H Ohta","year":"2012","unstructured":"Ohta H, Oka H, Usui C, Ohkura M, Suzuki M, Nishioka K. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia. Arthritis Res Ther. 2012;14:R217.","journal-title":"Arthritis Res Ther"},{"key":"106_CR29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1098\/rstb.2010.0384","volume":"366","author":"P Enck","year":"2011","unstructured":"Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S. The placebo response in clinical trials: more questions than answers. Philos Trans R Soc Lond B Biol Sci. 2011;366:1889\u201395.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"106_CR30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.mayocp.2012.02.010","volume":"87","author":"LM Arnold","year":"2012","unstructured":"Arnold LM, Clauw DJ, Dunegan LJ, Turk DC. A framework for fibromyalgia management for primary care providers. Mayo Clin Proc. 2012;87:488\u201396.","journal-title":"Mayo Clin Proc"},{"key":"106_CR31","doi-asserted-by":"publisher","unstructured":"Lobo CP, Pfalzgraf AR, Giannetti V, Kanyongo G. Impact of invalidation and trust in physicians on health outcomes in fibromyalgia patients. Prim Care Companion CNS Disord 2014;16: 10.4088\/PCC .","DOI":"10.4088\/PCC"},{"issue":"Suppl 1","key":"106_CR32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00228-011-0990-y","volume":"67","author":"P Baiardi","year":"2011","unstructured":"Baiardi P, Giaquinto C, Girotto S, Manfredi C, Ceci A. Innovative study design for paediatric clinical trials. Eur J Clin Pharmacol. 2011;67 Suppl 1:109\u201315.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-016-0106-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:34:01Z","timestamp":1498318441000},"score":1,"resource":{"primary":{"URL":"http:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-016-0106-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,30]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1186\/s12969-016-0106-4","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,30]]},"article-number":"46"}}